“…Thirteen studies reported the prevalence of LAC in patients with chronic airway diseases or smokers, including COPD [ 6 , 7 , 24 , 33 , 34 , 42 , 43 , 44 ], asthma [ 7 , 34 ], cystic fibrosis [ 39 ], emphysema [ 45 , 46 ], bronchiectasis [ 36 ] or pulmonary sarcoidosis [ 35 ]. We performed a meta-analysis for LAC prevalence in eight studies of patients either with COPD or asthma, as the number of studies on other respiratory conditions such as cystic fibrosis, emphysema or bronchiectasis was too small.…”